Southern Medical University, located in Guangzhou, Guangdong Province, is the only one of the first batch of national key universities in Guangdong Province, and it is also one of the first batch of eight universities in China that offer eight-year clinical medicine graduate students and doctoral degrees. It is the only medical college under the key construction of a high-level university in Guangdong Province, and the first batch of pilot universities in China to educate and train excellent doctors and excellent physicians (Chinese medicine).
The school has been selected into the national project of building a high-level university for public postgraduates, the training plan for top-notch students in basic discipline 2.0, the national "key discipline project with characteristics" and the first batch of pilot universities in China for excellent doctoral education and training plan.
The school, formerly known as the First Military Medical University of the Chinese People's Liberation Army, was founded in 195 1, 1979 and was designated as a national key university. In August 2004, it was transferred to Guangdong Province as a whole and renamed Southern Medical University.
Scientific research achievements of Southern Medical University:
As of March, 2002 1, our school has successively won 2 second prizes of national natural science, 2 second prizes of national technological invention 1, 65438+5 second prizes of national scientific and technological progress, 53 first prizes of provincial and ministerial level science and technology. Four scientific and technological achievements were selected as the top ten annual scientific and technological progress in China; Three consecutive five-year plans took the lead in undertaking major national scientific and technological projects for the prevention and treatment of infectious diseases and received rolling support; In 2020, it won 303 national natural funds.
In September, 2022, a new study involving Queensland University of Science and Technology, Griffith University, Xiamen University, Jiangnan University and Southern Medical University in China found that atmospheric pressure cold plasma can inhibit coronavirus from invading human cells, which laid the foundation for developing drugs such as nasal spray that can prevent COVID-19. Related papers were recently published in the Australian Journal of Diagnostics and Therapeutics.